Christopher Kurtz, based in San Diego, CA, US, is currently a Chief Medical Officer at Kate Therapeutics, bringing experience from previous roles at Stealth biotech startup and Amgen. Christopher Kurtz holds a 1996 - 2000 Bachelor of Science (BS) in Chemistry, with honors @ California Institute of Technology. With a robust skill set that includes Medical Education, Stress Testing, Transesophageal Echocardiography, Biotechnology, Cardiology and more, Christopher Kurtz contributes valuable insights to the industry. Christopher Kurtz has 2 emails on RocketReach.